Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$1.35B |
| 2 |
Microsoft
MSFT
|
+$1.33B |
| 3 |
S&P Global
SPGI
|
+$898M |
| 4 |
Advanced Micro Devices
AMD
|
+$845M |
| 5 |
Tesla
TSLA
|
+$823M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$307M |
| 4 |
Exelon
EXC
|
+$291M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| 1 | Technology | 25.4% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Red River Bancshares
RRBI
$432M
| $4.18M | ﹤0.01% |
78,973
+4,084
| +5% | +$216K |
|
2902
Amplitude
AMPL
$1.47B
| $4.18M | ﹤0.01% |
226,657
-6,983
| -3% | -$129K |
|
2903
GeneDx Holdings
WGS
$3.56B
| $4.17M | ﹤0.01% |
41,162
+1,421
| +4% | +$144K |
|
2904
UBS Group
UBS
$129B
| $4.17M | ﹤0.01% |
213,276
-3,555
| -2% | -$69.5K |
|
2905
Xoma
XOMA
$452M
| $4.16M | ﹤0.01% |
148,691
+1,983
| +1% | +$55.5K |
|
2906
RLX Technology
RLX
$3.18B
| $4.16M | ﹤0.01% |
2,339,998
-135,495
| -5% | -$241K |
|
2907
Vertex
VERX
$3.84B
| $4.16M | ﹤0.01% |
271,004
+3,620
| +1% | +$55.5K |
|
2908
Angi Inc
ANGI
$760M
| $4.14M | ﹤0.01% |
73,096
+331
| +0.5% | +$18.8K |
|
|
HLGN
2909
DELISTED
Heliogen, Inc.
HLGN
| $4.14M | ﹤0.01% |
+22,479
| New | +$4.14M |
|
2910
HF Foods Group
HFFG
$177M
| $4.13M | ﹤0.01% |
620,412
+31,710
| +5% | +$211K |
|
|
KNTE
2911
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $4.11M | ﹤0.01% |
365,103
+1,471
| +0.4% | +$16.6K |
|
2912
El Pollo Loco
LOCO
$304M
| $4.11M | ﹤0.01% |
353,668
+14,039
| +4% | +$163K |
|
2913
Matrix Service
MTRX
$353M
| $4.11M | ﹤0.01% |
499,564
+56,423
| +13% | +$464K |
|
2914
Spero Therapeutics
SPRO
$107M
| $4.1M | ﹤0.01% |
471,189
+14,005
| +3% | +$122K |
|
|
CBAY
2915
DELISTED
Cymabay Therapeutics
CBAY
| $4.1M | ﹤0.01% |
1,316,948
+165,743
| +14% | +$515K |
|
2916
Immunic
IMUX
$78.4M
| $4.08M | ﹤0.01% |
360,959
+40,959
| +13% | +$463K |
|
2917
Vroom, Inc. Common Stock
VRM
$137M
| $4.07M | ﹤0.01% |
19,139
-1,560
| -8% | -$332K |
|
2918
Citius Pharmaceuticals
CTXR
$20.6M
| $4.07M | ﹤0.01% |
90,886
+8,917
| +11% | +$399K |
|
2919
Aldeyra Therapeutics
ALDX
$324M
| $4.06M | ﹤0.01% |
912,868
+60,108
| +7% | +$267K |
|
|
DZSI
2920
DELISTED
DZS Inc. Common Stock
DZSI
| $4.05M | ﹤0.01% |
292,299
+17,485
| +6% | +$243K |
|
|
JNCE
2921
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.05M | ﹤0.01% |
596,615
-26,261
| -4% | -$178K |
|
|
AHT
2922
Ashford Hospitality Trust
AHT
$38.1M
| $4.04M | ﹤0.01% |
39,631
-983
| -2% | -$100K |
|
2923
Rimini Street
RMNI
$417M
| $4.04M | ﹤0.01% |
696,163
+26,159
| +4% | +$152K |
|
2924
Harvard Bioscience
HBIO
$19.7M
| $4.03M | ﹤0.01% |
649,325
+6,425
| +1% | +$39.9K |
|
2925
The ONE Group
STKS
$81.1M
| $4.03M | ﹤0.01% |
383,176
+23,881
| +7% | +$251K |
|